G0329 has existed since 2004. Most eligible patients still don't know.

What G0329 covers

HCPCS code G0329 — Electromagnetic therapy, to one or more areas — covers the use of FDA-cleared PEMF devices for the management of chronic wounds that have not responded to standard care. Medicare has maintained this coverage determination since 2004 through Local Coverage Determination L34428 (various MAC jurisdictions). No prior authorization is required in most contractor regions. The coverage applies to: Stage III or IV pressure ulcers; chronic arterial ulcers; diabetic foot ulcers; and venous stasis ulcers. The clinical threshold is non-response to 30 days of conventional wound management — a standard most chronic-wound patients have long since met.

The size of the eligible population

Approximately 8.2 million Americans have chronic wounds annually, generating an estimated $25 billion in direct healthcare costs. Diabetic foot ulcers precede approximately 100,000 amputations per year — amputations that adequate wound management could in many cases prevent. Stage III and IV pressure ulcers affect 2.5 million hospital and long-term care patients annually. The majority of these patients are Medicare-eligible by age or disability status. The utilization gap is not a coverage gap — the benefit exists. It is an awareness and access gap.

The clinical mechanism in wound healing

The 800% wound-healing acceleration documented in pressure-ulcer studies is driven by tPEMF's activation of NO-mediated angiogenesis — the formation of new capillaries in the wound bed. Chronic wounds stall in a persistent inflammatory phase; they cannot complete normal healing because the vascular supply to the wound bed is insufficient to support re-epithelialization. The tPEMF-induced NO cascade promotes vascular endothelial growth factor (VEGF) expression, accelerating the formation of new capillaries and breaking the inflammatory stall. The mechanism is well-characterized and consistent with the clinical results across studies.

Why the coverage goes unclaimed

The discharge process for wound-care patients — from hospital to home or to a skilled nursing facility — is focused on dressing protocols, antibiotic regimens, and follow-up appointments. The prescribing clinician may not be aware that G0329 exists or may not have time to document and order it. The patient almost certainly doesn't know. The result: a Medicare benefit that has existed for over two decades is functionally inaccessible to most of the patients it covers. The HealWithout wound-care surface (healwithout.com/wounds) is built to close this specific awareness gap — bringing the patient from 'I have a wound that isn't healing' to 'I have a Medicare benefit that covers a device for this' in one visit.

• No prior authorization required in most MAC jurisdictions
• Coverage applies at home — patient does not need to travel to a wound care center
• G0329 is distinct from hospital outpatient wound care billing — it is a home-use benefit
• The altru.care Rx engine handles the prescription documentation for G0329 qualification

Who this patient is

He is 68 years old with type 2 diabetes and a plantar wound on his left foot that has not closed in five months. He has been going to a wound-care clinic twice a week. He is on Medicare. He has never been told that Medicare covers a home device for exactly this type of wound. His wound-care nurse is excellent — she simply does not have time in a 20-minute dressing visit to explain G0329, and she may not know it applies to a home device rather than only to the clinic setting. He would prefer to manage more of his wound care at home. He is one clear answer away from using a Medicare benefit he has been paying into for 20 years.

What this means for prescribers

G0329 is a billable benefit — the prescribing clinician who documents the wound diagnosis, the failure of 30 days of standard care, and the medical necessity for electromagnetic therapy is billing a covered service, not asking a payer for an exception. The documentation is the standard wound-care record. No special prior authorization, no peer-to-peer review. For a wound-care practice managing chronic wound patients, adding PEMF to the treatment plan for qualifying patients with home-use G0329 billing is a covered service that extends the care episode into the patient's home without additional clinical visits.